MedPath

A STUDY OF SEDATIVE DRUGS COMBINATION OF NEW DRUG COMBINATION OF PROPOFOL- NALBUPHINE WITH PROPOFOL-KETAMINE FOR SURGICAL PROCEDURE OF ERCP(ENDOSCOPIC PROCEDURE)

Not Applicable
Conditions
Health Condition 1: K801- Calculus of gallbladder with othercholecystitis
Registration Number
CTRI/2022/07/043893
Lead Sponsor
ARAYANA MEDICAL COLLEGE NELLORE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

PATIENTS POSTED ERCP

WEIGHT 30 TO 70KG

BMI LESS THAN 35

ASA GRADE 1 AND 2

Exclusion Criteria

PATIENTS NOT GIVING CONSENT

PATIENTS WITH DIFFICULT AIRWAY

PATIENTS ASA 3 AND ABOVE

PREGNANCY

ALLERGY TO STUDY DRUGS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HAEMODYNAMIC PARAMETERS BETWEEN TWO GROUPS <br/ ><br>SIDE EFFECTS BETWEEN TWO GROUPSTimepoint: HAEMODYNAMIC PARAMETERS BETWEEN TWO GROUPS AT 5 10 ,15,30 45 MINUTES <br/ ><br>SIDE EFFECTS BETWEEN TWO GROUPS
Secondary Outcome Measures
NameTimeMethod
TIME FOR SEDATION ONSET <br/ ><br>TIME FOR COMPLTE RECOVERY <br/ ><br>Timepoint: OBSERVATION FOR BIS INDEX EVERY 10 MINUTES FOR 1 HOUR <br/ ><br>OBSERVATION FOR POSTOPERATIVE RECOVERY AT 6 HOURS 8 HOURS 10 HOURS 12 HOURS 24 HOURS
© Copyright 2025. All Rights Reserved by MedPath